Client Payment Portal

Canada Launches New Immigration Stream for Ukrainians

Jun 16, 2022 | Consular Services & Travel, Global, Human Resources Services, Humanitarian Resources

The Canada-Ukraine Authorization for Emergency Travel (CUAET) allows Ukrainian nationals to apply for a Canadian visa without most of the usual requirements (free of charge, exempt from completing an immigration medical exam overseas, the option to apply for an open work permit, exempt from Canada’s COVID-19 vaccination requirements) excepting biometrics in certain cases and ArriveCAN. Announced on March 17, 2022, the CUAET is particularly interesting for Ukrainians as compared to other visas available because it allows them to obtain an open work permit and/or study permit free of charge, and they can be authorized to stay in Canada up to three years instead of the standard six months. For non-complex cases, the aim is to approve such visa applications within 14 days of receipt. No sponsor in Canada is required, no ties to home country are to be considered, and there are no financial requirements.

To apply for CUAET, Ukrainians need to apply for a Temporary Resident Visa and an Open Work Permit by mentioning in their application that it is made through CUAET to highlight the urgency of the demand to the visa officers. Once the application is submitted, Ukrainians need to take biometrics only if they are aged 18 to 60. Then they normally would need to submit their passport for placement of Canadian Visa (although Canadian authorities now emit counterfoil-less visas if the applicant is in one of six departure countries: Poland, Germany, Slovakia, Hungary, Austria, or Romania).

On April 28, 2022, Canada received 163,747 applications and approved 56,633, and 19,628 Ukrainians arrived in Canada. As there is no limit on the number of CUAET applications of CUAET, it is a popular and successful program, according to reports.

Details:

Related Posts:

State Department Releases January Visa Bulletin – Charlie Oppenheim Comments

The State Department has released the January Visa Bulletin. Below are highlights along with commentary from WR Immigration’s Director of Visa Consulting Charlie Oppenheim on the Visa Bulletin updates, many of which he predicted in his December 15, 2022, “Chatting with Charlie” webinar. Related: Chatting with Charlie webinar series continues in January! See upcoming dates>> EB-1: All countries remain current, except for India and China, which as predicted during the December 15 Chatting with Charlie, an EB-1 Final Action Date (FAD) of February 1, 2022 has been imposed for both India and China and an Application Filing Date (AFD) for adjustment filing for cases with priority dates earlier than June 1, 2022. USCIS will publish on its Visa Bulletin web page whether they will allow either the AFD or FAD to be used for the filing of adjustment of status applications for January. EB-2: The India EB-2 India FAD remains unchanged at October 8, 2011, and the India AFD remains unchanged at May 1, 2012. China EB-2 remains unchanged at June 8, 2019. All other countries stay on November 1, 2022. EB-3 Professionals and Skilled Workers: The India EB-3 FAD will remains unchanged at June 15, 2012, and the AFD remains unchanged at August 1, 2012. The China EB-3 FAD remains unchanged at August 1, 2018, and the AFD stays on September 1, […]

Read More

HR’s Crucial Role in Life Sciences IPOs

Much attention has been given to venture investments in New England life sciences companies. Private funding is creating an incredible lift for lab space, office space, hiring, and overall innovation. IPOs, however, deserve as much recognition. Larger and fast-growing companies are heading for the Street, with nearly 50 U.S. biotech companies filing to go public in the first half of 2021. Those IPOs combined to raise nearly $9 billion (as of June 30, 2021). The momentum is carrying forward from the record-breaking pace of 2020, however, it’s reasonable to expect this will slow at some point. A report by Silicon Valley Bank noted that post-IPO performance is lagging, which could lower the appetite for more biotechs and pharma on Wall Street. Regardless, activity in 2021 looks to be at least near the peak IPO numbers of 2020. With IPOs come new shareholders to satisfy, analyst scrutiny, more rigorous reporting obligations, and a whole new business strategy. Every part of the organization has its work cut out for it, and human resources (HR) is no exception. As HR leaders plan pre- and post-IPO priorities for the workforce, they should: Understand the impact on the overall workforce IPOs can fundamentally change the direction and priorities of […]

Read More